Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

2020 Episode 5 - Identifying and Managing Renal Complications in Patients with T2D and CVD

2020 Episode 5 - Identifying and Managing Renal Complications in Patients with T2D and CVD

FromKnow Diabetes by Heart™ Professional Education Podcast Series


2020 Episode 5 - Identifying and Managing Renal Complications in Patients with T2D and CVD

FromKnow Diabetes by Heart™ Professional Education Podcast Series

ratings:
Length:
33 minutes
Released:
Jun 25, 2020
Format:
Podcast episode

Description

People with type 2 diabetes and chronic kidney disease are at three times higher risk of dying from a cardiovascular event. According to the National Kidney Foundation, the two main causes of chronic kidney disease are diabetes and high blood pressure. These two conditions were the primary diagnosis in 75% of kidney failure cases between 2015-2017. Listen to Dr. George Bakris, a nephrologist with expertise in diabetes-related kidney disease, and Dr. Peter McCullough, a cardiologist who is also board certified in internal medicine, discuss how to better screen and manage patients with type 2 diabetes who are at risk for cardiovascular disease and renal disease.
Released:
Jun 25, 2020
Format:
Podcast episode

Titles in the series (33)

The American Heart Association and the American Diabetes Association are excited to announce a new podcast series for healthcare professionals. Know Diabetes by Heart™ Professional Education Podcast Series focuses on the link between cardiovascular disease (CVD) and type 2 diabetes (T2D). The series will consist of relevant cutting-edge topics such as up-to-date standards of care, guidelines and their implications for T2D and CVD, and approaches to shared decision making—among others. The American Heart Association’s and the American Diabetes Association's Know Diabetes by Heart Professional Education™ Podcast Series is brought to you by founding sponsors, Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsors, Sanofi, AstraZeneca, and Bayer.